By David Cassak | June 2011
- OrthoSensor is building a three-legged platform, with intelligent implants, and analytics, all driven by sensor and other micro-electronics technology that feed back to surgeons vital data both intra- and post-operatively.
- Critical to OrthoSensor’s strategy: that improving outcomes in orthopedic surgery rests on developing better, data-rich surgical techniques, rather than novel implants made of new materials or design features.
- OrthoSensor has already begun to form corporate partnerships, including one with Stryker, and is convinced it can prove that “instruments sell implants” and that its novel technology can move market share.
- OrthoSensor still has to prove the clinical benefit of data-driven orthopedics, but the company’s biggest decision may come in whether it continues to partner with large implant companies or develops its own line of implants.
ACCESS FULL PDF OF ARTICLE FROM IN VIVO
CLICK FOR MORE ORTHOSENSOR NEWS